HIGHLIGHTS
- who: Brendan T. Finicle and colleagues from the Department of Developmental and Cell Biology, University of California Irvine, Irvine, CA, USA, Ionis Pharmaceuticals, Carlsbad, CA, USA, Siege Pharmaceuticals, Irvine, CA, USA, Department of Molecular Biology and Biochemistry, University of California Irvine, Irvine, CA, USA, Department of Chemistry, Universitu00e9 de Montru00e9al, Montru00e9al, QC, Canada and , Department of Pharmaceutical Sciences, University of California Irvine, Irvine, CA, USA have published the paper: Simultaneous inhibition of endocytic recycling and lysosomal fusion sensitizes cells and tissues to oligonucleotide therapeutics, in the Journal: (JOURNAL)
- what: The authors show that the well . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.